John Ransom
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Little Rock, ARNPI 1477513778
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.8%), consulting fees and education — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Briohealth Solutions, Inc. at 43.9% of the total. 2025 is the largest year on record at $5,024, 2.5 times the $2,035 reported in 2019.
Across 312 payments — averaging $37.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Briohealth Solutions, Inc.$5K
- Abbott$2K
- Novartis$698
- Actelion Pharmaceuticals US, Inc.$674
- Abiomed$560
- Alnylam Pharmaceuticals Inc.$403
- plus $2K from 26 others
Across 77 payments — averaging $5429.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$418K
What the payments were for
- Consulting fees$5,00043%
- Food & beverage$6,57057%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Briohealth Solutions, Inc. | 3 | $5,077 |
| Abbott | 69 | $1,973 |
| Novartis | 48 | $698 |
| Actelion Pharmaceuticals US, Inc. | 32 | $674 |
| Abiomed | 14 | $560 |
| Alnylam Pharmaceuticals Inc. | 19 | $403 |
| Boehringer Ingelheim | 25 | $400 |
| AstraZeneca | 21 | $342 |
| United Therapeutics Corporation | 13 | $248 |
| Pfizer | 12 | $178 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $155 |
| Amgen | 10 | $153 |
| Astellas Pharma US Inc | 7 | $148 |
| Davol Inc. | 2 | $88 |
| Sanofi-aventis U.S. LLC | 5 | $68 |
| Lexicon Pharmaceuticals, Inc. | 4 | $68 |
| Baxter Healthcare | 1 | $44 |
| Haemonetics Corporation | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Livanova USA, Inc. | 1 | $29 |
| Paragonix Technologies, Inc. | 1 | $28 |
| Octapharma USA, Inc. | 1 | $26 |
| AbbVie | 1 | $22 |
| Irhythm Technologies, Inc. | 1 | $20 |
| Boston Scientific | 1 | $17 |
| Novo Nordisk | 1 | $17 |
| Bayer | 1 | $15 |
| Akcea Therapeutics, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,572 in reported general payments places this provider in the 70th percentile of 48 thoracic surgery (cardiothoracic vascular surgery) providers in Arkansas.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Arkansas →
Other thoracic surgery (cardiothoracic vascular surgery) in Little Rock
- Bassam ShukrallahLittle Rock$325K
- Pouya HemmatiLittle Rock$168K
- Katy MarinoLittle Rock$99K
- Charles ColeLittle Rock$23K
- Karol MudyLittle Rock$21K
- Jason MuesseLittle Rock$20K
- Kristofer FreelandLittle Rock$16K
- Michael NolenLittle Rock$15K
- John StreitmanLittle Rock$14K
- David DeanLittle Rock$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.